Clinical trial
Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other…
NCT00462553 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00462553 |
|---|---|
| Title | Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors |
| Official title | A Phase I Study of Sunitinib Malate and Standard Infusion Gemcitabine in Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | sunitinib malate, gemcitabine hydrochloride |
| Enrollment | 37 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2010 |
| First posted | Apr 19, 2007 |
| Last update posted | Feb 24, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: